IntraTherapeutics IntraCoil PMA Foiled By Widespread Off-Label Stenting

Sulzer/IntraTherapeutics said it will continue efforts to win FDA approval of its IntraCoil stent for use in the popliteal and femoral arteries, despite the rampant off-label use of other stents for the indication.

More from Archive

More from Medtech Insight